ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACHL Achilles Therapeutics PLC

0.92
-0.0197 (-2.10%)
01 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.09M
Operating Income -17.46M
Pre Tax Income -17.46M
Net Income -17.51M
Preferred Dividends 0
Basic Earnings Per Share (EPS) 0
EBIT -17.46M
EBITDA -17.46M
Year End 31 December 2022 2019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0531k3.13M7.32M
Operating Income -13.76M-33.2M-61.06M-71.13M
Pre Tax Income -13.99M-33.2M-61.06M-71.07M
Net Income -13.99M-33.2M-61.1M-71.18M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 0000
EBIT -13.98M-33.2M-61.06M-71.13M
EBITDA -13.46M-32.42M-61.06M-59.99M